​
Login / Signup
Chia-Hsin Liu
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 6
Top Topics
Brain Metastases
Advanced Non Small Cell Lung Cancer
Tyrosine Kinase
Free Survival
Top Venues
International journal of molecular sciences
OncoTargets and therapy
Respirology case reports
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Cheng-Yin Liu
,
Chia-Hsin Liu
Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR -Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion.
OncoTargets and therapy
17 (2024)
Cheng-Yin Liu
,
Chia-Hsin Liu
Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR -Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion.
OncoTargets and therapy
17 (2024)
Chia-Hsin Liu
,
Yuan-Pu Peter Di
Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes.
International journal of molecular sciences
24 (3) (2023)
Chia-Hsin Liu
,
Yuan-Pu Peter Di
Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes.
International journal of molecular sciences
24 (3) (2023)
Chia-Hsin Liu
,
Yuan-Pu Peter Di
Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes.
International journal of molecular sciences
24 (3) (2023)
Chi-Wei Shih
,
Yi-Jia Lin
,
Hung-Yi Yang
,
Chia-Hsin Liu
An unusual cause of pleural effusion.
Respirology case reports
9 (9) (2021)